Filter
137
Text search:
European
Medicines
Agency
EMA
Featured
Recommendations
19
New Publications
31
Language
Document type
No document type
48
Guidelines
37
Studies & Reports
21
Fact sheets
18
Manuals
8
Situation Updates
2
Strategic & Response Plan
2
Training Material
1
Countries / Regions
Western and Central Europe
5
Germany
4
West and Central Africa
3
Global
3
Brazil
2
East and Southern Africa
2
Guinea
1
Sierra Leone
1
Liberia
1
Congo, Democratic Republic of
1
Ethiopia
1
Uganda
1
Philippines
1
Nepal
1
Zambia
1
Kenya
1
Cambodia
1
Thailand
1
Indonesia
1
Bangladesh
1
Argentina
1
Ukraine
1
Ecuador
1
Latin America and the Carribbean
1
Paraguay
1
Africa
1
Venezuela
1
Eastern Europe
1
Denmark
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
27
Countries
19
Pharmacy & Technologies
6
Women & Child Health
5
Key Resources
2
Capacity Building
1
Public Health
1
Toolboxes
COVID-19
31
AMR
25
HIV
8
TB
8
Pharmacy
8
Ebola & Marburg
7
Malaria
7
Rapid Response
5
NTDs
4
Refugee
3
Zika
3
Planetary Health
3
Mental Health
2
Disability
1
Natural Hazards
1
9 April 2020
WHO has published the guidance “Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected” This document is intended for clinicians taking care of hospitalized adult and paediatric patients with severe acute respiratory infection (SARI) whe
...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
Issue Brief 8th edition.
The objective of this document is to guide the preparation and implementation of national preparedness plans for the safety of substances of human origin during outbreaks of Zika virus infection, both in affected and non-affected areas.
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact
...
8 March 2022
A very large number of people from Ukraine are fleeing the country and entering the European Union (EU) countries bordering Ukraine (Hungary, Poland, Romania, Slovakia) and the EU-neighbourhood country of the Republic of Moldova. Those
...
March 2022. This report on good practices to combat AMR focuses on activities across human, animal, and environmental health in European countries. The report provides a description of practices, how they were implemented, achievements, and why the
...
A One Health Response. A Briefing Note
Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. Arlington, VA: Management Sciences for Health. Submitted to the United Nations Children’s Fund by JSI, Arl
...
This policy brief has been developed in response to the contemporary challenge of antibiotic resistance (ABR). ABR poses a formidable threat to global health and sustainable development. It is now increasingly recognized that the systematic neglect of cultural factors is one of the biggest obs
...
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we
...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation
...
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Gr
...
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-
...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen
...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f
...
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This
...
